Chromatin Adaptor Brd4 Modulates E2 Transcription Activity and Protein Stability*

  1. Cheng-Ming Chiang§,1
  1. Simmons Comprehensive Cancer Center and the Departments of §Pharmacology and Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-8807
  1. 1 To whom correspondence should be addressed: Simmons Comprehensive Cancer Center, Bldg. ND2.210H, 5323 Harry Hines Blvd., Dallas, TX 75390-8807. Tel.: 214-645-6128; Fax: 214-645-6347; E-mail: cheng-ming.chiang{at}utsouthwestern.edu.

Abstract

Brd4 is a chromatin adaptor containing tandem bromodomains binding to acetylated histone H3 and H4. Although Brd4 has been implicated in the transcriptional control of papillomavirus-encoded E2 protein, it is unclear how Brd4 regulates E2 function and whether the involvement of Brd4 in transactivation and transrepression is common to different types of E2 proteins. Using DNase I footprinting performed with in vitro reconstituted human papillomavirus (HPV) chromatin and nucleosome-free DNA templates, we found that Brd4 facilitates E2 binding to its cognate sequences in chromatin depending on bromodomains and the E2-interacting region of Brd4. Moreover, the coactivator and corepressor function of Brd4 requires at least one intact bromodomain and is mediated by its direct association with E2 proteins encoded by cancer-inducing high risk HPV-16 and HPV-18, wart-causing low risk HPV-11, and bovine papillomavirus type 1, in part through enhancing the protein stability of E2 that is normally degraded via the ubiquitin-dependent proteasome pathway. Our findings indicate that a chromatin adaptor can bridge and enhance the binding of a sequence-specific transcription factor to chromatin and further promote the stability of a labile transcription factor via direct protein-protein interaction.

Footnotes

  • * This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760. This work is report CSCN 041 from the University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Received July 30, 2008.
  • Revision received November 25, 2008.
Table of Contents

This Article

  1. The Journal of Biological Chemistry 284, 2778-2786.
  1. All Versions of this Article:
    1. M805835200v1
    2. 284/5/2778 (most recent)

Article Usage Stats

Submit your work to JBC.

You'll be in good company.